CCM
EVH icon

Cadian Capital Management’s Evolent Health EVH Stock Holding History

Cadian Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.6M Hold
10,814,473
– – 4.44% 9
2026
Q1 		$24.7M Sell
10,814,473
-270,982
-2% -$860K 3% 13
2025
Q4 		$44.3M Sell
11,085,455
-643,469
-5% -$3.58M 3.2% 13
2025
Q3 		$99.2M Buy
11,728,924
+1,304,223
+13% +$12.7M 5.9% 7
2025
Q2 		$117M Sell
10,424,701
-369,905
-3% -$3.4M 6.57% 4
2025
Q1 		$102M Buy
10,794,606
+5,569,605
+107% +$56.3M 4.37% 9
2024
Q4 		$58.8M Buy
+5,225,001
New +$91.8M 3.38% 13
2017
Q4 		– Sell
-940,000
Closed -$16.7M – 31
2017
Q3 		$16.7M Buy
+940,000
New +$19.4M 0.78% 30

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cadian Capital Management's EVH Position: Q2 2026 in Review

Cadian Capital Management held its Evolent Health (EVH) position steady in Q2 2026 at 10,814,473 shares worth $58.6M. The position accounts for 4.44% of the portfolio, ranked #9.

Cadian Capital Management first reported a position in EVH in Q3 2017 and has held it in 8 quarters since. The position peaked at $117M in Q2 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Cadian Capital Management held 10,814,473 shares of Evolent Health worth $58.6M as of Q2 2026.
  • Cadian Capital Management left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 4.44% of Cadian Capital Management's portfolio in Q2 2026, its #9 holding.
  • Cadian Capital Management first reported a position in Evolent Health in Q3 2017 and has held it in 8 quarters since.
  • Cadian Capital Management's Evolent Health position peaked at $117M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Cadian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.